← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
26	T. Rowe Price Investment Management Baltimore, Maryland	$532M	-$2.97M	7	0.34%	Reduced
27	JP Morgan Chase New York	$488M	-$166K	69	0.03%	Reduced
28	Avoro Capital Advisors New York	$478M	-$191M	4	8.38%	Reduced
29	Renaissance Technologies New York	$456M	+$77.5M	57	0.61%	Increased
30	SCM Suvretta Capital Management New York	$438M	+$28.8M	10	13.22%	Increased
31	D.E. Shaw & Co New York	$426M	+$402M	21	0.3%	Increased
32	Allspring Global Investments Charlotte, North Carolina	$407M	+$92.9M	11	0.68%	Increased
33	Charles Schwab San Francisco, California	$402M	+$11.7M	48	0.07%	Increased
34	Millennium Management New York	$397M	+$152M	58	0.19%	Increased
35	T. Rowe Price Associates Baltimore, Maryland	$388M	-$277M	37	0.04%	Reduced
36	Perceptive Advisors New York	$384M	-$15.4M	8	14.22%	Reduced
37	Farallon Capital Management San Francisco, California	$379M	-$67.5M	8	1.59%	Reduced
38	Principal Financial Group Des Moines, Iowa	$371M	-$18M	12	0.2%	Reduced
39	Paradigm Biocapital Advisors New York	$365M	+$51M	3	15.57%	Increased
40	Two Sigma Investments New York	$359M	+$149M	49	0.64%	Increased
41	NMC NEA Management Company Timonium, Maryland	$344M	$0	6	25.92%	Maintained
42	Balyasny Asset Management Chicago, Illinois	$341M	+$163M	18	0.51%	Increased
43	RA Capital Management Boston, Massachusetts	$337M	+$23M	7	5.68%	Increased
44	Frazier Life Sciences Management Palo Alto, California	$330M	+$10.3M	7	13.18%	Increased
45	Capital International Investors Los Angeles, California	$319M	-$430M	3	0.06%	Reduced
46	Vestal Point Capital New York	$305M	-$19.5M	11	16.08%	Reduced
47	Wells Fargo San Francisco, California	$293M	-$39.6M	70	0.06%	Reduced
48	Citadel Advisors Miami, Florida	$288M	-$249M	63	0.05%	Reduced
49	Armistice Capital New York	$286M	-$29.8M	9	4.94%	Reduced
50	Two Sigma Advisers New York	$277M	+$146M	33	0.57%	Increased